Cochlear Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHEOY research report →
Range $117 – $117
Price Chart
About the company
Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world. The company's diverse product range features cochlear implant systems, enhanced sound processor upgrades, bone conduction technology, and a variety of complementary accessories and related items.
- CEO
- Diggory William Howitt
- IPO
- 2010
- Employees
- 5,500
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on CHEOY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.31B
- P/E
- 61.57
- Fwd P/E
- 18.30
- PEG
- -0.99
- P/S
- 3.88
- P/B
- 5.21
- EV/EBITDA
- 22.32
- Div Yield
- 3.10%
- Gross Margin
- 70.53%
- Op Margin
- 12.89%
- Net Margin
- 6.31%
- ROE
- 8.01%
- ROIC
- 10.16%
Latest fiscal year · YoY change
- Revenue
- $2.35B+0.2%
- Gross Profit
- $1.66B-4.0%
- Op Income
- $209.20M
- Net Income
- $147.30M-62.1%
- EPS
- $0.00-100.0%
- OCF Growth
- +54.9%
- FCF Growth
- +105.4%
- 52W High
- $104.65
- 52W Low
- $31.82
- 50D MA
- $41.98
- 200D MA
- $62.71
- Beta
- 0.26
- RSI (14)
- 66
- Avg Volume
- 61.20K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the CHEOY Q4 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 49.8%
- Shares Outstanding
- 130.80M
- Float Shares
- 65.13M
of shares held by institutions
4 13F filers
Congressional trading
Senate and House stock disclosures for CHEOY, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Daniel GoldmanHouse · NY10 | Sell | Jul 10, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Held by 1 ETFs
Biggest fund positions in CHEOY by dollar value.
Our CHEOY coverage
Recent articles, reports, and earnings notes.
No research on CHEOY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CHEOY report →Cochlear Limited (CHEOY) Q4 2026 Earnings Call Transcript
seekingalpha.com · Aug 18
CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Sees Significant Drop in Short Interest
defenseworld.net · Aug 15
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
newsfilecorp.com · Jul 14
Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants
prnewswire.com · May 29
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant
newsfilecorp.com · May 11
MED-EL USA Presents Real World Clinical Insights to Support Tailored Hearing Solutions at the 2026 American Cochlear Implant Association Meeting
businesswire.com · Apr 29
Cochlear Limited (CHEOY) Q3 2026 Sales/Trading Call Transcript
seekingalpha.com · Apr 22
Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact
reuters.com · Apr 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.